TheBCR/ABLTransgene Causes Abnormal NK Cell Differentiation and Can Be Found in Circulating NK Cells of Advanced Phase Chronic Myelogenous Leukemia Patients-Reference-Cited by-同舟云学术

TheBCR/ABLTransgene Causes Abnormal NK Cell Differentiation and Can Be Found in Circulating NK Cells of Advanced Phase Chronic Myelogenous Leukemia Patients

Published:2002-01-15 Issue:2 Volume:168 Page:643-650
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Nakajima Hikaru,Zhao Robert,Lund Troy C.,Ward Jeanne,Dolan Michelle,Hirsch Betsy,Miller Jeffrey S.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture

2. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis

3. Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity

4. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture

5. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of low skeletal muscle mass on NK cells in patients with acute myeloid leukemia and its correlation with prognosis;Annals of Hematology;2024-01-31

2. Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha;British Journal of Haematology;2023-07-22

3. Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response;Frontiers in Medicine;2023-03-07

4. Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies;Current Hematologic Malignancy Reports;2022-10-19

5. The prognostic role of NKG2A expression for patients with chronic myeloid leukemia after treatment discontinuation;Leukemia & Lymphoma;2022-06-25